Specific immunotherapy in atopic dermatitis - Four-year treatment in different age and airborne allergy type subgroups

Acta Dermatovenerologica Croatica

Volumn 14, Issue 4, 2006, Pages 230-240

  Czarnecka Operacz, Magdalena ^a,b   Silny, Wojciech ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b NONE   (Poland)

Author keywords

Allergy; Atopic dermatitis; Specific immunotherapy; Treatment

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTIPRURITIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENT; VACCINE;

ADULT; ALLERGY; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GRASS POLLEN; HOUSE DUST ALLERGY; HUMAN; IMMUNOTHERAPY; INFECTION; LYMPHOMA; MALE; PATIENT ASSESSMENT; PRURITUS; SCORING SYSTEM; SENSITIZATION; SKIN INFLAMMATION; SLEEP DISORDER; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; UNSPECIFIED SIDE EFFECT; VACCINATION;

ADOLESCENT; ADULT; ALLERGENS; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOTHERAPY; MALE; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 33846506766     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hanifin J, Saurat JH. Proceedings of the International Consensus Conference on Atopic Dermatitis. Rome, Italy, November 5-6, 1999. J Am Acad Dermatol 2001;45:S1-68.
2. Ellis C, Luger T. International Consensus Conference on Atopic Dermatitis II (ICCAD II). Chairman's introduction and overview. Br J Dermatol 2003;148:3-10.
3. Sidbury R, Hanifin JM. Systemic therapy of atopic dermatitis. Clin Exp Derm 2000;25:559-60.
4. Silny W, Czarnecka-Operacz M, Gołȩbka E, Silny P. W-AZS a new scoring index for patients with atopic dermatitis. Przegl Dermatol 1999;86:215-22.
5. Czarnecka-Operacz M, Bator-Wegner M, Silny W. Atopy patch test reaction to airborne allergens in the diagnosis of atopic dermatitis. Acta Dermatovenereol Croat 2005;13:3-16.
6. Hanifin JM, Schneider LC, Leung DYM, Ellis CN, Jaffe HC, Izu AE, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993;28:189-97.
7. Schneider LC, Baz Z, Zarcone C, Zurakowski D. Long-term therapy with recombinant interferon-gamma (rIFN-gamma) for atopic dermatitis. Ann Allergy Asthma Immunol 1998;80:263-8.
8. Jang IG, Yang JK, Lee HJ, Yi JY, Kim HO, Kim CW, et al. Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma. J Am Acad Dermatol 2000;42:1033-40.
9. Noon L, Cantab BO. Prophylactic inoculation against hay fever. Lancet 1911;1:1572-3.
10. Bousquet J, Lockey RF, Malling HJ. WHO position paper. Allergen immunotherapy - therapeutic vaccines for allergic diseases. Allergy 1998;53:1-42.
11. Boquete M, Carballada F, Exposito F, Gonzalez A. Preventive immunotherapy. Allergol Immunopathol 2000;28:89-93.
12. Sendin I. Evaluation of pediatric aspects of the WHO document and meta-analysis of immunotherapy. Allergol Immunopathol 2000;29:82-9.
13. Mastrandrea F. Immunotherapy in atopic dermatitis. Exp Opin Invest Drugs 2001;10:49-63.
14. Glover MT, Atherton DJ. A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exp Allerg 1992;22:440-6.
15. Leroy BP, Lachapelle JM, Somville MM, Jacquemin MG, Saint-Remy JM. Injection of allergen-antibody complexes is an effective treatment of atopic dermatitis. Dermatologica 1991;182:98-106.
16. Kaufman HS, Roth HL. Hyposensitization with alum precipitated extracts in atopic dermatitis: a placebo controlled study. Ann Allergy 1974;32:321-30.
17. Ring J. Successful hyposensitization treatment in atopic eczema: results of a trial in monozygotic twins. Br J Dermatol 1982;93:597-602.
18. Silny W, Czarnecka-Operacz M. Specific immunotherapy in the treatment of patients with atopic dermatitis - results of double blind placebo controlled study. In press.
19. Theodoropoulos DS, Lockey RF. Allergen immunotherapy: guidelines, update and recommendations of the World Health Organization. Allergy Asthma Proc 2000;21:159-66.
20. Silny W, Czarnecka-Operacz M. Specific immunotherapy in the treatment of atopic dermatitis. Alergia Astma Immunol 1999;4 (Suppl 2):85-7.
21. Silny W, Czarnecka-Operacz M. Specific immunotherapy in the treatment of patients with atopic dermatitis. Rev Fr Alergol 1999;56 (Numero special):87-8.
22. Silny W, Czarnecka-Operacz M. Possible application of specific immunotherapy in the treatment of atopic dermatitis - modulation of immune response. Alergia Astma Immunol 2000;5 (Suppl 1):31-4.
23. Czarnecka-Operacz M, Silny W. Specific immunotherapy in selected cases of atopic dermatitis. Przewodnik Lekarza 2001;3:118-21.
24. Silny W, Czarnecka-Operacz M. Atopic dermatitis - new methods of treatment. Przewodnik Lekarza 2002;3:48-56.
25. Czarnecka-Operacz M. Specific immunotherapy in the treatment of patients with atopic dermatitis. Poznań: Poznańskie Zakłady Graficzne SA, 2000.
26. Czarnecka-Operacz M. Allergy vaccines in the treatment of atopic dermatitis. Int Rev Allergol Clin Immunol 2001;7:5-8.
27. Czarnecka-Operacz M. Total IgE and antigen specific IgE in patients with atopic dermatitis and airborne allergy treated with specific immunotherapy. Int Rev Allergol Clin Immunol 2001;7:16-26.
28. Czarnecka-Operacz M, Silny W, Sobieska M. Serum levels of IFN-γ, IL-2R, IL-4, IL-5 and IL-10 in the course of specific immunotherapy of patients with atopic dermatitis. Int Rev Allergol Clin Immunol 2001;7:27-33.